ANDA 84714, held by Abc Holding. Hydrochlorothiazide; Reserpine.
As of Nov 16, 2026, ANDA 84714 (Hydro-Reserp), held by Abc Holding, was first approved by FDA on Nov 20, 1979, with 7 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 20, 1979 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Hydro-Reserp50MG;0.125MG ยท tablet;oral | Hydrochlorothiazide; Reserpine | Discontinued |
| Mar 19, 1992 | Supplement 15Labeling | Approved | None posted |
| Dec 31, 1991 | Supplement 14Labeling | Approved | None posted |
| Nov 6, 1989 | Supplement 12Labeling | Approved | None posted |
| Feb 11, 1983 | Supplement 8Manufacturing | Approved | None posted |
| Jun 29, 1982 | Supplement 2Manufacturing | Approved | None posted |
| Jun 29, 1982 | Supplement 3Manufacturing | Approved | None posted |
| Nov 2, 1981 | Supplement 6Manufacturing | Approved | None posted |
| Nov 20, 1979 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters